Fig. 6: Competition ELISA of purified IgGs from individual mouse sera from day 56 after immunization. | npj Vaccines

Fig. 6: Competition ELISA of purified IgGs from individual mouse sera from day 56 after immunization.

From: Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity

Fig. 6

Each datum represents the mean of duplicate experiments for each IgG sample. IgGs were diluted to a final concentration of 100 μg/mL and used to compete for binding to antibodies against antigenic domains A (CBH4B), B (AR3A and HEPC74), D (HC84.1 and HC84.26), and E (HCV1).

Back to article page